103 related articles for article (PubMed ID: 16518530)
1. Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects.
Marketou ME; Zacharis EA; Nikitovic D; Ganotakis ES; Parthenakis FI; Maliaraki N; Vardas PE
Angiology; 2006; 57(2):211-8. PubMed ID: 16518530
[TBL] [Abstract][Full Text] [Related]
2. Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia.
Kowalski J; Okopień B; Madej A; Zieliński M; Belowski D; Kalina Z; Herman ZS
Eur J Clin Pharmacol; 2003 Jul; 59(3):189-93. PubMed ID: 12756509
[TBL] [Abstract][Full Text] [Related]
3. Early outcome of acute ischemic stroke in hyperlipidemic patients under atorvastatin versus simvastatin.
Lampl Y; Lorberboym M; Gilad R; Vysberg I; Tikozky A; Sadeh M; Boaz M
Clin Neuropharmacol; 2010 May; 33(3):129-34. PubMed ID: 20502132
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
Milionis HJ; Papakostas J; Kakafika A; Chasiotis G; Seferiadis K; Elisaf MS
J Clin Pharmacol; 2003 Aug; 43(8):825-30. PubMed ID: 12953339
[TBL] [Abstract][Full Text] [Related]
5. Effects of simvastatin and atorvastatin on inflammation markers in plasma.
Wiklund O; Mattsson-Hultén L; Hurt-Camejo E; Oscarsson J
J Intern Med; 2002 Apr; 251(4):338-47. PubMed ID: 11952885
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein antibody titers are reduced by statin therapy in dyslipidemic subjects: a pilot study.
Ghayour-Mobarhan M; Lamb DJ; Vaidya N; Livingstone C; Wang T; Ferns GA
Angiology; 2005; 56(1):61-8. PubMed ID: 15678257
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients.
Ascer E; Bertolami MC; Venturinelli ML; Buccheri V; Souza J; Nicolau JC; Ramires JA; Serrano CV
Atherosclerosis; 2004 Nov; 177(1):161-6. PubMed ID: 15488879
[TBL] [Abstract][Full Text] [Related]
8. Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients.
Paolisso G; Barbagallo M; Petrella G; Ragno E; Barbieri M; Giordano M; Varricchio M
Atherosclerosis; 2000 May; 150(1):121-7. PubMed ID: 10781642
[TBL] [Abstract][Full Text] [Related]
9. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.
Buldak L; Dulawa-Buldak A; Labuzek K; Okopien B
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):805-13. PubMed ID: 22943927
[TBL] [Abstract][Full Text] [Related]
10. The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress.
Mulder DJ; van Haelst PL; Wobbes MH; Gans RO; Zijlstra F; May JF; Smit AJ; Tervaert JW; van Doormaal JJ
Cardiovasc Drugs Ther; 2007 Apr; 21(2):91-7. PubMed ID: 17342417
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
Kumar A; Sharma N; Gupta A; Kalonia H; Mishra J
Brain Res; 2012 Aug; 1471():13-22. PubMed ID: 22789904
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular event rates in atorvastatin patients versus patients switching from atorvastatin to simvastatin.
Jacobson TA; Wertz DA; Kuznik A; Cziraky M
Curr Med Res Opin; 2013 Jul; 29(7):773-81. PubMed ID: 23647370
[TBL] [Abstract][Full Text] [Related]
13. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.
Milionis HJ; Kakafika AI; Tsouli SG; Athyros VG; Bairaktari ET; Seferiadis KI; Elisaf MS
Am Heart J; 2004 Oct; 148(4):635-40. PubMed ID: 15459594
[TBL] [Abstract][Full Text] [Related]
14. Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin.
Nawawi H; Osman NS; Annuar R; Khalid BA; Yusoff K
Atherosclerosis; 2003 Aug; 169(2):283-91. PubMed ID: 12921980
[TBL] [Abstract][Full Text] [Related]
15. No effect of atorvastatin and simvastatin on oxidative stress in patients at high risk for cardiovascular disease.
Scheffer PG; Schindhelm RK; van Verschuer VM; Groenemeijer M; Simsek S; Smulders YM; Nanayakkara PW
Neth J Med; 2013 Sep; 71(7):359-65. PubMed ID: 24038561
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects of simvastatin versus atorvastatin on oxidative stress in patients with coronary heart disease.
Li J; Sun YM; Wang LF; Li ZQ; Pan W; Cao HY
Clin Cardiol; 2010 Apr; 33(4):222-7. PubMed ID: 20394043
[TBL] [Abstract][Full Text] [Related]
17. Hemostatic effects of atorvastatin versus simvastatin.
Kadikoylu G; Yukselen V; Yavasoglu I; Bolaman Z
Ann Pharmacother; 2003 Apr; 37(4):478-84. PubMed ID: 12659599
[TBL] [Abstract][Full Text] [Related]
18. MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis.
Nachtigal P; Pospisilova N; Pospechova K; Jamborova G; Kopecky M; Jaynes R; Briestensky J; Santar I; Smahelova A; Solichova D; Zdansky P; Semecky V
Life Sci; 2006 Mar; 78(17):1983-9. PubMed ID: 16305803
[TBL] [Abstract][Full Text] [Related]
19. LDL-C goal attainment in patients who remain on atorvastatin or switch to equivalent or non-equivalent doses of simvastatin: a retrospective matched cohort study in clinical practice.
Rublee DA; Burke JP
Postgrad Med; 2010 Mar; 122(2):16-24. PubMed ID: 20203452
[TBL] [Abstract][Full Text] [Related]
20. [Oxidation stress, insulin resistance and endothelial dysfunction during the treatment of hyperlipidaemia].
Zeman M; Vecka M; Stopka P; Zahin M; Tvrzická E; Stanková B; Vareka T; Janíková L; Zák A
Cas Lek Cesk; 2006; 145(12):923-8. PubMed ID: 17323614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
